Philippe A. Halban

Philippe A. Halban's AcademicInfluence.com Rankings

Philippe A. Halban

Philosophy

#9651

World Rank

#13240

Historical Rank

Logic

#6620

World Rank

#8153

Historical Rank

philosophy Degrees

Philippe A. Halban

Biology

#13293

World Rank

#16833

Historical Rank

Endocrinology

#205

World Rank

#218

Historical Rank

Biochemistry

#2317

World Rank

#2465

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Philippe A. Halban's Degrees

PhD Biochemistry University of Geneva
Doctorate Medicine University of Geneva

Why Is Philippe A. Halban Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Philippe A. Halban's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. (1992) (1088)
Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. (2002) (732)
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells (2011) (716)
Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis* (2003) (549)
Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications (2004) (428)
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) (402)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. (2002) (384)
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. (2003) (325)
Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. (2008) (312)
Sorting and processing of secretory proteins. (1994) (302)
Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. (2004) (253)
Proliferation of sorted human and rat beta cells (2007) (245)
SNAP-25 is expressed in islets of Langerhans and is involved in insulin release (1995) (238)
Regulation of immunoreactive-insulin release from a rat cell line (RINm5F). (1983) (222)
Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. (2003) (218)
Cytokine production by islets in health and diabetes: cellular origin, regulation and function (2010) (216)
Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. (2000) (211)
Islet Inflammation and Fibrosis in a Spontaneous Model of Type 2 Diabetes, the GK Rat (2006) (192)
The possible importance of contact between pancreatic islet cells for the control of insulin release. (1982) (190)
Extracellular matrix protects pancreatic beta-cells against apoptosis: role of short- and long-term signaling pathways. (2004) (187)
Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway (1987) (176)
Glucose-stimulated insulin secretion is coupled to the interaction of actin with the t-SNARE (target membrane soluble N-ethylmaleimide-sensitive factor attachment protein receptor protein) complex. (2003) (176)
Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome (2013) (163)
FLIP switches Fas-mediated glucose signaling in human pancreatic β cells from apoptosis to cell replication (2002) (157)
Regulation of pancreatic β-cell insulin secretion by actin cytoskeleton remodelling: role of gelsolin and cooperation with the MAPK signalling pathway (2006) (153)
Intracellular degradation of insulin stores by rat pancreatic islets in vitro. An alternative pathway for homeostasis of pancreatic insulin content. (1980) (148)
Dominant-Negative Effects of a Novel Mutated Ins2 Allele Causes Early-Onset Diabetes and Severe β-Cell Loss in Munich Ins2C95S Mutant Mice (2007) (140)
A clathrin-coated, golgi-related compartment of the insulin secreting cell accumulates proinsulin in the presence of monensin (1984) (138)
Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines. (2003) (138)
Spontaneous Reassociation of Dispersed Adult Rat Pancreatic Islet Cells Into Aggregates With Three-Dimensional Architecture Typical of Native Islets (1987) (135)
Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. (1994) (134)
Insulin resistance in HIV protease inhibitor-associated diabetes. (1999) (132)
Insulin, not C-peptide (proinsulin), is present in crinophagic bodies of the pancreatic B-cell (1984) (127)
β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. (2014) (125)
Interleukin-6 regulates pancreatic α-cell mass expansion (2008) (123)
Blockade of β1 Integrin–Laminin-5 Interaction Affects Spreading and Insulin Secretion of Rat β-Cells Attached on Extracellular Matrix (2006) (111)
Blockade of membrane transport and disassembly of the Golgi complex by expression of syntaxin 1A in neurosecretion-incompetent cells: prevention by rbSEC1. (1999) (108)
Mutational analysis of VAMP domains implicated in Ca2+‐induced insulin exocytosis. (1996) (106)
Bimodal Effect on Pancreatic β-Cells of Secretory Products From Normal or Insulin-Resistant Human Skeletal Muscle (2011) (105)
Oligomerization of green fluorescent protein in the secretory pathway of endocrine cells. (2001) (105)
Pioglitazone and sodium salicylate protect human β-cells against apoptosis and impaired function induced by glucose and interleukin-1β (2004) (104)
Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? (2001) (104)
SNAP-23 Is Not Cleaved by Botulinum Neurotoxin E and Can Replace SNAP-25 in the Process of Insulin Secretion* (1997) (104)
Sorting Ourselves Out: Seeking Consensus on Trafficking in the Beta‐Cell (2004) (101)
Current status of islet cell replacement and regeneration therapy. (2010) (101)
Impaired NH2-Terminal Processing of Human Proislet Amyloid Polypeptide by the Prohormone Convertase PC2 Leads to Amyloid Formation and Cell Death (2006) (99)
Uvomorulin mediates calcium-dependent aggregation of islet cells, whereas calcium-independent cell adhesion molecules distinguish between islet cell types. (1991) (99)
Cellular sources of new pancreatic β cells and therapeutic implications for regenerative medicine (2004) (99)
Impact of integrin-matrix matching and inhibition of apoptosis on the survival of purified human beta-cells in vitro (2002) (98)
Abnormal glucose metabolism accompanies failure of glucose to stimulate insulin release from a rat pancreatic cell line (RINm5F). (1983) (97)
Functional differences between rat islets of ventral and dorsal pancreatic origin. (1982) (96)
Autonomous and self-sustained circadian oscillators displayed in human islet cells (2012) (96)
Differences in aggregation properties and levels of the neural cell adhesion molecule (NCAM) between islet cell types. (1990) (96)
Activation of NF-κB by Extracellular Matrix Is Involved in Spreading and Glucose-stimulated Insulin Secretion of Pancreatic Beta Cells* (2005) (95)
In Vivo Modulation of Gap Junctions and Dye Coupling Between B-Cells of the Intact Pancreatic Islet (1983) (95)
Role of β-Cell Prohormone Convertase (PC)1/3 in Processing of Pro-Islet Amyloid Polypeptide (2004) (93)
Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor (2002) (90)
Novel Insulinoma Cell Lines Produced by Iterative Engineering of GLUT2, Glucokinase, and Human Insulin Expression (1997) (90)
Dual effect of cell-cell contact disruption on cytosolic calcium and insulin secretion. (2008) (88)
Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells (2005) (88)
The Fas pathway is involved in pancreatic β cell secretory function (2007) (87)
Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. (1999) (80)
Circulating Follistatin Is Liver-Derived and Regulated by the Glucagon-to-Insulin Ratio. (2016) (79)
Gap junction development is correlated with insulin content in the pancreatic B cell. (1980) (79)
pH-independent and -dependent cleavage of proinsulin in the same secretory vesicle (1994) (77)
Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic Beta cell (1991) (75)
Long-term exposure of isolated pancreatic islets to mannoheptulose: Evidence for insulin degradation in the β cell (1980) (75)
Differential rates of release of newly synthesized and of stored insulin from pancreatic islets. (1982) (74)
A new, rapid, method for preparation of dispersed pancreatic acini. (1985) (70)
Differential expression of E-cadherin at the surface of rat beta-cells as a marker of functional heterogeneity. (2007) (69)
B-cell size influences glucose-stimulated insulin secretion. (1993) (67)
Focal Adhesion Remodeling Is Crucial for Glucose-Stimulated Insulin Secretion and Involves Activation of Focal Adhesion Kinase and Paxillin (2011) (67)
Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia (1997) (66)
Importance of Cell-Matrix Interactions in Rat Islet-Cell Secretion In Vi t r o Role of 6 1 Integrin (2000) (66)
Insulin degradation by hepatocytes in primary culture. (1981) (66)
Trafficking/sorting and granule biogenesis in the beta-cell. (2000) (65)
Identification and Characterization of α3β1 Integrin on Primary and Transformed Rat Islet Cells (1997) (64)
Increasing GLP-1–Induced β-Cell Proliferation by Silencing the Negative Regulators of Signaling cAMP Response Element Modulator-α and DUSP14 (2008) (63)
Novel Mechanistic Link between Focal Adhesion Remodeling and Glucose-stimulated Insulin Secretion* (2011) (63)
Stimulation by ATP of proinsulin to insulin conversion in isolated rat pancreatic islet secretory granules. Association with the ATP-dependent proton pump. (1987) (63)
Blockade of beta1 integrin-laminin-5 interaction affects spreading and insulin secretion of rat beta-cells attached on extracellular matrix. (2006) (62)
Small Interfering RNA–Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in Culture (2008) (61)
NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro (2001) (61)
Munc 18‐1 and Granuphilin Collaborate During Insulin Granule Exocytosis (2008) (60)
Processing of proinsulin by transfected hepatoma (FAO) cells. (1992) (60)
Absorption kinetics of subcutaneously injected insulin (1979) (59)
Role of the Rho-ROCK (Rho-associated kinase) signaling pathway in the regulation of pancreatic beta-cell function. (2009) (59)
Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation. (1998) (57)
Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta. (2004) (56)
Role of beta-cell prohormone convertase (PC)1/3 in processing of pro-islet amyloid polypeptide. (2004) (56)
Isolation of pancreatic islets and primary culture of the intact microorgans or of dispersed islet cells. (1990) (56)
Nonconverted, amino acid analog-modified proinsulin stays in a Golgi- derived clathrin-coated membrane compartment (1984) (55)
Induction of CXCL1 by extracellular matrix and autocrine enhancement by interleukin-1 in rat pancreatic beta-cells. (2007) (55)
Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. (2005) (55)
b-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and (2014) (55)
In Vitro Proliferation of Adult Human Beta-Cells (2012) (54)
Pharmacokinetics of Subcutaneously Injected Tritiated Insulin: Effects of Exercise (1979) (54)
Intracellular pathways of insulin transport across vascular endothelial cells. (1988) (52)
Levels of the conversion endoproteases PC1 (PC3) and PC2 distinguish between insulin-producing pancreatic islet beta cells and non-beta cells. (1994) (52)
Partial diversion of a mutant proinsulin (B10 aspartic acid) from the regulated to the constitutive secretory pathway in transfected AtT-20 cells. (1989) (51)
Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription (2003) (51)
Membrane localization and biological activity of SNAP-25 cysteine mutants in insulin-secreting cells. (2000) (49)
Silencing Mitogen-activated Protein 4 Kinase 4 (MAP4K4) Protects Beta Cells from Tumor Necrosis Factor-α-induced Decrease of IRS-2 and Inhibition of Glucose-stimulated Insulin Secretion* (2009) (49)
Rab GTPase-Activating Protein AS160 Is a Major Downstream Effector of Protein Kinase B/Akt Signaling in Pancreatic β-Cells (2008) (49)
The skeleton in the closet: actin cytoskeletal remodeling in β-cell function. (2015) (49)
Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix. (2009) (48)
Effects of aging on insulin synthesis and secretion. Differential effects on preproinsulin messenger RNA levels, proinsulin biosynthesis, and secretion of newly made and preformed insulin in the rat. (1988) (47)
SNAP-25a and -25b isoforms are both expressed in insulin-secreting cells and can function in insulin secretion. (1999) (47)
Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus. (1996) (46)
Proinsulin processing in the regulated and the constitutive secretory pathway (1994) (45)
Inositol 1,4,5-trisphosphate receptor subtype 3 in pancreatic islet cell secretory granules revisited. (1996) (44)
Kinetics of Proinsulin Conversion in Human Islets (1993) (43)
Sorting human beta-cells consequent to targeted expression of green fluorescent protein. (1998) (43)
Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. (2008) (43)
Dynamin Is Functionally Coupled to Insulin Granule Exocytosis* (2007) (43)
Trafficking of non-regulated secretory proteins in insulin secreting (INS-1) cells (2000) (43)
The Effect of Aprotinin on the Absorption of Subcutaneously Injected Regular Insulin in Normal Subjects (1980) (42)
Proinsulin Conversion in GH3 Cells After Coexpression of Human Proinsulin With the Endoproteases PC2 and/or PC3 (1997) (40)
Dispersed adult rat pancreatic islet cells in culture: A, B, and D cell function. (1984) (40)
Phosphorylation of SNAP-25 on serine-187 is induced by secretagogues in insulin-secreting cells, but is not correlated with insulin secretion. (2002) (36)
Human proinsulin conversion in the regulated and the constitutive pathways of transfected AtT20 cells. (1994) (36)
Identification and characterization of alpha 3 beta 1 integrin on primary and transformed rat islet cells. (1997) (35)
Identification of functional insulin receptors on membranes from an insulin-producing cell line (RINm5F). (1985) (35)
Processing of Proinsulin by Furin, PC2, and PC3 in (Co) Transfected COS (Monkey Kidney) Cells (1995) (34)
Role of clathrin in the regulated secretory pathway of pancreatic beta-cells. (2001) (32)
Elevated Proinsulin Biosynthesis In Vitro from a Rat Model of Non-insulin-dependent Diabetes Mellitus (1983) (32)
Non-muscle myosin IIA is involved in focal adhesion and actin remodelling controlling glucose-stimulated insulin secretion (2013) (32)
The preparation of a semisynthetic tritiated insulin with a specific radioactivity of up to 20 Curies per millimole. (1975) (32)
Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats. (1981) (32)
Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II. (1991) (32)
Binding and Degradation of Semisynthetic Tritiated Insulin by IM-9 Cultured Human Lymphocytes (1980) (31)
Deletion of a highly conserved tetrapeptide sequence of the proinsulin connecting peptide (C-peptide) inhibits proinsulin to insulin conversion by transfected pituitary corticotroph (AtT20) cells. (1989) (31)
Increased intracellular calcium is required for spreading of rat islet beta-cells on extracellular matrix. (2001) (31)
Novel, non-crinophagic, degradation of connecting peptide in transformed pancreatic beta cells. (1993) (31)
Resistance of the insulin crystal to lysosomal proteases: implications for pancreatic B-cell crinophagy (1987) (31)
Tumor necrosis factor-alpha modifies adhesion properties of rat islet B cells. (1993) (30)
Perturbation of hormone storage and release induced by cyproheptadine in rat pancreatic islets in vitro. (1979) (30)
Slow cleavage at the proinsulin B-chain/connecting peptide junction associated with low levels of endoprotease PC1/3 in transformed beta cells. (1993) (28)
Influence of Glucose on Insulin Handling by Rat Islets in Culture: A Reflection of Integrated Changes in Insulin Biosynthesis, Release, and Intracellular Degradation (1983) (28)
Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα (2014) (26)
Pro-Survival Role of Gelsolin in Mouse β-Cells (2007) (26)
RESISTANCE AGAINST SUBCUTANEOUS INSULIN SUCCESSFULLY MANAGED WITH APROTININ (1980) (26)
Hypoglycaemia caused by atypical insulin antibodies in a patient with benign monoclonal gammopathy (1993) (26)
Des-(27-31)C-Peptide (1996) (25)
Inhibition of proinsulin to insulin conversion in rat islets using arginine and lysine analogs. Lack of effect on rate of release of modified products. (1982) (25)
The ratio of mouse insulin I:insulin II does not reflect that of the corresponding preproinsulin mRNAs (1992) (24)
The intracellular handling of insulin-related peptides in isolated pancreatic islets. Evidence for differential rates of degradation of insulin and C-peptide. (1988) (22)
Short Term Exposure of Beta Cells to Low Concentrations of Interleukin-1β Improves Insulin Secretion through Focal Adhesion and Actin Remodeling and Regulation of Gene Expression* (2015) (21)
Hypercholesterolaemia, signs of islet microangiopathy and altered angiogenesis precede onset of type 2 diabetes in the Goto–Kakizaki (GK) rat (2011) (21)
Sequence requirements for proinsulin processing at the B-chain/C-peptide junction. (1995) (21)
Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model (2013) (21)
Regenerating 1 and 3b Gene Expression in the Pancreas of Type 2 Diabetic Goto-Kakizaki (GK) Rats (2014) (21)
Bimodal impact of skeletal muscle on pancreatic β‐cell function in health and disease (2012) (21)
IL-13 improves beta-cell survival and protects against IL-1beta-induced beta-cell death (2015) (20)
Glucose-induced b cell production of IL-1 b contributes to glucotoxicity in human pancreatic islets (2018) (20)
Proinsulin trafckin and processing in the pancreatic B cell (1990) (19)
In Vitro Studies on Biosynthetic Human Insulin: an Overview (1981) (18)
Pro-survival role of gelsolin in mouse beta-cells. (2007) (17)
Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor. (1979) (16)
Mobilization of subcutaneously injected tritiated insulin in rats: Effects of muscular exercise (1978) (16)
Mutant proinsulin that cannot be converted is secreted efficiently from primary rat beta-cells via the regulated pathway. (2003) (15)
The degradation of semisynthetic tritiated insulin by perfused mouse livers. (1976) (15)
Establishment and culture of insulin-secreting beta cell lines. (1990) (15)
Altered differentiated cell surface properties of transformed (RINm5F) compared with native adult rat pancreatic B cells. (1988) (15)
DIAMAP: A Road Map for Diabetes Research in Europe (2011) (14)
Diabetes research investment in the European Union (2006) (14)
Heterogeneity of expression and secretion of native and mutant [AspB10]insulin in AtT20 cells. (1991) (13)
Cell therapy for type 2 diabetes: is it desirable and can we get it? (2008) (13)
Distribution and metabolism of intravenously injected tritiated insulin in rats. (1979) (13)
Adaptation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of posttranscriptional regulation. (1993) (12)
Bimodal Effect on Pancreatic β-Cells of Secretory Products From Normal or Insulin-Resistant Human Skeletal Muscle. Diabetes 2011;60:1111–1121 (2014) (12)
Glucagon-like Peptide-1 Receptor Signaling Modulates (2002) (11)
High-performance liquid chromatography analysis of circulating insulins distinguishes between endogenous insulin production (a potential pitfall with streptozotocin diabetic rats) and islet xenograft function (1990) (11)
High-performance liquid chromatography (HPLC): A rapid, flexible and sensitive method for separating islet proinsulin and insulin (1986) (11)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Truncated (des-[27–31]) C-peptide is not a major secretory product of human islets (2002) (11)
The GM2-1 Ganglioside Islet Autoantigen in Insulin-Dependent Diabetes Mellitus Is Expressed in Secretory Granules and Is Notβ -Cell Specific. (1998) (11)
Isolation of pancreatic islets of Langerhans by filtration on nylon mesh. (1978) (10)
In vitro and in vivo studies on glucagonoma tissue. (1980) (10)
Short term exposure of beta cells to low concentrations of interleukin-1β improves insulin secretion through focal adhesion and actin remodeling and regulation of gene expression. (2015) (10)
Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells (1993) (9)
Islet B-cell dysfunction and the time course of recovery following chronic overinsulinisation of normal rats (1988) (9)
Role of clathrin in the regulated secretory pathway of pancreatic β-cells (9)
SNAP-25 can self-associate to form a disulfide-linked complex. (1997) (9)
Molecular strategies for the treatment of diabetes. (1994) (8)
Proinsulin modified by analogues of arginine and lysine is degraded rapidly in pancreatic B-cells. (1984) (8)
50 years forward: beta cells (2015) (8)
Prime time for DIAMAP: a road map for diabetes research in Europe (2010) (8)
The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific. (1998) (8)
Diabetes resistant to subcutaneous insulin: effect of aprotinin. (1981) (7)
Long-term exposure of isolated pancreatic islets to mannoheptulose: evidence for insulin degradation in the beta cell. (1980) (7)
The Chemical Characterization of the Products of the Processing of Subcutaneously Injected Insulin (1980) (6)
Order! Order! Order in the House! (2008) (5)
Production of insulin antibodies by mice rejecting insulin transfected cells. (1989) (4)
Tris(hydroxymethyl)aminomethane Inhibits the Synthesis and Processing of Proinsulin in Isolated Rat Pancreatic Islets Without Affecting Release of Insulin Stores (1986) (4)
Modulation by sodium butyrate of the differentiated status of a clonal pancreatic B-cell line (RIN). (1989) (4)
Sorting Human -Cells Consequent to Ta r g e t e d Expression of Green Fluorescent Protein (1998) (4)
Insulin production: from gene to granule (1997) (3)
Comparison of 125 I-Insulin and [B1- 3 H-Phenylalanine]- Insulin Degradation by Insulin Protease (1980) (2)
Proinsulin conversion intermediates: a possible source of confusion (1991) (2)
Erratum. Small Interfering RNA—Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in Culture. Diabetes 2008;57:3045—3055 (2016) (2)
Activation of liver and muscle insulin receptor tyrosine kinase activity during in vivo insulin administration in rats (1990) (2)
DIAMAP: an innovative blueprint for the future of diabetes research in Europe (2010) (2)
Towards a perfect beta cell replacement. (2004) (2)
GLUT2 or not GLUT2? That is the question (1997) (2)
10th EASD/JDRF Oxford Workshop. What is a beta-cell and can we improve it? (2005) (2)
A road map for European diabetes research: DIAMAP (2008) (2)
The innovative medicines initiative (IMI): a shot in the arm for European diabetes research? (2007) (2)
A new paradigm for improved co-ordination and efficacy of European biomedical research: taking diabetes as a model (2013) (1)
Degradation of pork insulin and biosynthetic human insulin in vitro and in vivo: a comparative study. (1981) (1)
Insulin production: from gene to granule (1997) (1)
Publish and flourish: seasonal advice to our readers (1995) (1)
Rab-GAP AS160 is a major downstream effector of PKB/Akt signaling in pancreatic beta-cells (2008) (1)
[How to explain the rebirth of the beta cell in terms of sacrifice and delivery]. (2007) (0)
Thank you Vienna—over to you, Bristol (2004) (0)
EASD News Sections October 2002 (2002) (0)
Leptin modulates (cid:1) cell expression of IL-1 receptor antagonist and release of IL-1 (cid:1) in human islets (2004) (0)
Comment faire renaître la cellule beta du sacrifice en sauveur (2007) (0)
Immunofluorescence analysis of t-PA in human endothelial cells (1998) (0)
[Biosynthesis of insulin: intracellular traffic and enzymatic transformations]. (1991) (0)
Editorial Board (1992) (0)
study of substrate specificity in the conversion of proinsulin by PC 3 . MATERIALS AND METHODS Materials The expression (2005) (0)
Sponsor, leader and lobbyist: The European Foundation for the Study of Diabetes (EFSD) and the future of diabetes research in Europe (2000) (0)
The right stuff: (cid:1) -cell channels, cycles, and sensors (2008) (0)
Editorial Board (2010) (0)
The right stuff: beta-cell channels, cycles, and sensors. (2008) (0)
Levels of the conversion endoproteases PCi (PC3) and PC2 distinguish between insulin-producing pancreatic islet cells and non-f cells (2005) (0)
Focal adhesion remodelling is crucial for glucose-stimulated insulin secretion in pancreatic beta cells (2011) (0)
TT Proinsulin in the Same Secretory Vesicle (1994) (0)
Biosynthèse de l'insuline: trafic intracellulaire et transformations enzymatiques (1991) (0)
Erratum to: Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model (2013) (0)
Focal Adhesion Kinase (FAK) activity is crucial for beta cell glucose-stimulated insulin secretion (2009) (0)
Some Inhibitors of Insulin Degradation (1980) (0)
(cid:2) -Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) (0)
SORTING OF PROTEINS DESTINED FOR THE REGULATED SECRETORY PATHWAY (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Philippe A. Halban?

Philippe A. Halban is affiliated with the following schools:

Philippe A. Halban's Academic­Influence.com Rankings

Philippe A. Halban's Degrees

Why Is Philippe A. Halban Influential?

Philippe A. Halban's Published Works

Published Works

What Schools Are Affiliated With Philippe A. Halban?

Philippe A. Halban's AcademicInfluence.com Rankings